Table 1 Clinical and laboratory characteristics of the study population
Parameter | Simvastatin plus ezetimibe N = 50 | Rosuvastatin N = 51 | P value |
|---|---|---|---|
Age (years), | 59 (52–65) | 58 (55–64) | 0.78 |
Males, n (%) | 39 (76) | 36 (72) | 0.77 |
Smokers, n (%) | 34 (67) | 37 (74) | 0.56 |
Hypertensives, n (%) | 36 (71) | 36 (72) | 0.77 |
Diabetes, n (%) | 16 (31) | 19 (38) | 0.62 |
BMI, kg/m2 | 26.9 (24.0–31.4) | 25.3 (24.2–27.8) | 0.47 |
HbA1c (%) | 6.0 (5.5–6.7) | 6.0 (5.6–6.7) | 0.60 |
Glucose, mg/dL | 129 (99–169) | 121 (105–167) | 0.78 |
hsTNT, ng/L | 5881 (2273–12,231) | 5985 (2409–10,020) | 0.55 |
Creatinine, mg/dL | 0.90 (0.79–1.11) | 0.89 (0.77–1.00) | 0.35 |
GFR, mL/min/m2 | 86 (70–93) | 86 (73–98) | 0.79 |
SBP, mm Hg | 125 (110–137) | 126 (111–137) | 0.64 |
DBP, mm Hg | 80 (67–83) | 78 (71–89) | 0.48 |
Culprit coronary artery | |||
Left anterior descending, n (%) | 25 (50) | 26 (51) | 0.92 |
Right coronary artery, n (%) | 18 (36) | 19 (37) | 0.90 |
Left circumflex artery, n (%) | 7 (14) | 6 (12) | 0.74 |